ARTL · Artelo Biosciences Inc
United States · RS rating 28 · As of 2026-10-14
| Price | 2.88 USD |
|---|---|
| 1-day change | -3.4% |
| RS rating (overall / 1M / 3M / 12M) | 28 / 3 / 98 / 7 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 32 / 24 / 54 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +77.8% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +77.1% |
| Market cap (USD) | $3.7M |